In case you missed it, this week we covered AAFPRS’s annual study results, facemask dermatitis and more.
This week in aesthetics, Russell Health discusses their stem cell recruitment therapy, Epionce explains the link between sunscreen and skin barrier health and AAFPRS’s annual survey reveals younger patient trends. Industry executives paint an optimistic picture of an aesthetic market rebound, Viper Equity Partners talk smart consolidation, Dr. Anna Chacon offers treatments for facemask dermatitis and Cutera launches a campaign honoring COVID-19 first responders.
Russell Health: Stem Cell Recruitment Therapy
The framework of the products behind Russell Health’s mission to provide physicians with products and tissues to help the body heal itself.
Epionce: Sunscreen and Skin Barrier Health
Not only does a healthy skin barrier protect against external environmental factors, it also protects against active ingredient absorption to deeper skin levels.
AAFPRS Survey Reveals Younger Patients Trend
The annual survey released by the AAFPRS reveals increases in millennial patients, minimally invasive procedures and the power of social media on the aesthetic patient.
Aesthetic Market Shows Signs of Rebound
Industry executives paint optimistic picture of the near-future state of the aesthetic specialty.
Viper Equity Partners: Smart Consolidation In Aesthetics
Smart consolidation in aesthetics is finally here and investors are paying top dollar for practices.
Facemask Dermatitis: Symptoms and Solutions
Dermatologist Anna Chacon, M.D., offers treatment tips for common facemask-related issues, including acne mechanica, irritant contact dermatitis and more.
Cutera Launches Campaign Honoring COVID-19 Heroes
Cutera announces the launch of “Heroes Among Us,” an initiative honoring its customers exhibiting extraordinary compassion, humanitarianism and kindness during COVID-19.